Detalles de la búsqueda
1.
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755516
2.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696053
3.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578596
4.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649648
5.
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion.
EJHaem;
5(2): 369-378, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38633128
6.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol;
29(5): 545-550, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517658
7.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(5): 559-563, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538963
8.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol;
29(5): 535-544, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494578
9.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(5): 551-558, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526621
10.
The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia.
Bone Marrow Transplant;
59(4): 541-549, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321271
11.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(4): 355-362, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353907
12.
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).
Int J Hematol;
119(1): 24-38, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38015362
13.
Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).
Int J Hematol;
119(2): 130-145, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091231
14.
Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry.
Bone Marrow Transplant;
59(1): 125-127, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37805626
15.
Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.
Intern Med;
63(7): 993-998, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558474
16.
Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.
Int J Hematol;
119(1): 39-49, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38103160
17.
IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma?
Life (Basel);
13(11)2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38004369
18.
Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman's disease types: Implications for the mTOR signaling pathway.
Clin Immunol;
256: 109798, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778714
19.
[Onco-cardiology Guideline-Trends in Japan].
Gan To Kagaku Ryoho;
50(9): 943-949, 2023 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-37800284
20.
Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant.
J Infect Chemother;
29(12): 1103-1108, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532223